Nicolas Fischer

This inventor holds 32 USPTO granted patents and 20 published patent applications, plus 4 CIPO patents and 15 EPO patents, primarily in Bispecific Antibodies. Top assignees: Novimmune Sa, Legochem Biosciences, Inc., Novlmmune S.a.. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicolas Fischer. Retrieved from https://idiyas.com/inventor/nicolas-fischer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 32 (Patent Applications = 20)

% Patents Active = 93.8

CIPO Patents = 4 (Patent Applications = 10)

EPO Patents = 15 (Patent Applications = 26)

Average Co-Inventor Count = 4.2

ph-index = 6

Forward Citations = 255(Granted Patents)

Location History:

Geneve, CH (2010)
Geneva, CH (2010 - 2023)

Company Filing History:

Legochem Biosciences, Inc.

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

Areas of Expertise:

Bispecific Antibodies

Anti-CD47

Antibody Drug Conjugates

Multispecific Antibodies

Anti-CD3

Anti-TLR4

Hetero-Multimeric Proteins

Antibody Purification

Synthetic Polypeptide Libraries

Anti-Interferon Gamma

Anti-RANTES

Anti-IP-10

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12448444 - Bispecific antibodies targeting CD47 and PD-L1 and methods of use thereof (2025-10-21),

2. 11840553 - Anti-CD47 antibodies and methods of use thereof (2023-12-12),

3. 11827703 - Compositions and methods related to anti-CD19 antibody drug conjugates (2023-11-28),

4. 11401299 - Generating multispecific antibody mixtures and methods of uses thereof (2022-08-02),

5. 11261262 - Readily isolated bispecific binding molecules with native format having mutated constant regions (2022-03-01),

6. 11260117 - Anti-CD47 x anti-mesothelin antibodies and methods of use thereof (2022-03-01),

7. 11203646 - Anti-CD3 epsilon antibodies and methods of use thereof (2021-12-21),

8. 11059910 - Anti-CD47 antibodies and methods of use thereof (2021-07-13),

9. 10982004 - Anti-TLR4 antibodies and uses thereof (2021-04-20),

10. 10759858 - Anti-CD3 antibodies and methods of use thereof (2020-09-01),

11. 10689461 - Antibody dual display dual compositions and methods of use thereof (2020-06-23),

12. 10597465 - Methods for the generation of multispecific and multivalent antibodies (2020-03-24),

13. 10494446 - Readily isolated bispecific antibodies with native immunoglobulin format (2019-12-03),

14. 10400044 - Anti-TLR4 antibodies and uses thereof (2019-09-03),

15. 10113193 - Method for optimizing the assembly and production of hetero-multimeric protein complexes (2018-10-30),

Title: Inventor Nicolas Fischer: Pioneering Innovations in Geneva

Introduction: Nicolas Fischer is a renowned inventor based in Geneva, Switzerland, known for his groundbreaking contributions to various technological fields.

Latest Patents: Nicolas Fischer holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Nicolas Fischer has worked for leading research institutions and tech companies, where he has spearheaded projects that have revolutionized industries.

Collaborations: Throughout his career, Nicolas Fischer has collaborated with top engineers, scientists, and designers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Inventor Nicolas Fischer's relentless pursuit of innovation and his passion for creating cutting-edge solutions have solidified his reputation as a visionary in the field of technology.

Profile summary based on public USPTO records.